Analytical Data
-
Gene name
SLC7A6OS
- Application
-
Alternative Names
2010007L18Rik; 2400002F02Rik; ADAMS proteinase-related protein; FLJ13291; MGC60796; Protein SLC7A6OS; S7A6O_HUMAN; SLC7A6OS; Solute carrier family 7 member 6 opposite strand; Solute carrier family 7 member 6 opposite strand transcript
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96CW6
-
Expression Region
1-309 aa
-
AA Sequence
MERTAVLR VKRKRSAEPA EALVLACKRL RSDAVESQ KTSEGLER ENNVFHLVAT VCSQEEPVQP LLREVLRPSR DSQQRVRRNL RASAREVRQE GRYRVLSSRR SLGTTSSGQE SEYTPGNPEA AGNSGFQLLD LVHEEGEPEA ASAGSCKTSD PDVILCNSVE LIRERLTVSE DGPGVRRQEE QKHDDYVYDI YYLETATPGW IENILSVQPY SQEWELVNDD QEPEDIYDDE DDENSENNWR NEYPEEESSD GDEDSRGSAD YNSLSEEERG SSRQRMWSKY PLDVQKEFGY DSPHDLDSD
-
Molecular Weight
35.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC7A6OS, a long non-coding RNA (lncRNA), has gained attention in recent years due to its involvement in various biological processes and potential implications in human diseases. Initially discovered through genomic studies, SLC7A6OS is located on chromosome 4 and is believed to play a regulatory role in gene expression, particularly in the context of cellular stress responses and cancer progression. Emerging evidence suggests that SLC7A6OS interacts with different proteins and microRNAs, influencing pathways related to cell proliferation, apoptosis, and metastasis. Given its significant role in post-transcriptional regulation, researchers are increasingly interested in understanding the functional mechanisms of SLC7A6OS. The recombinant protein studies of SLC7A6OS aim to delineate its structural properties and interactions, offering insights into its regulatory functions at the molecular level. Such research may contribute to the development of novel therapeutic approaches targeting SLC7A6OS in various diseases, including cancers and neurodegenerative disorders. Furthermore, understanding the role of SLC7A6OS in the cellular context and its potential as a biomarker could pave the way for innovative strategies in precision medicine. Overall, the exploration of SLC7A6OS as a recombinant protein holds promise for advancing our knowledge of lncRNAs and their significance in human health and disease.
